Hologic, Inc (HOLX) concluded trading on Thursday at a closing price of $75.09, with 2.84 million shares of worth about $213.22 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 4.09% during that period and on December 12, 2024 the price saw a loss of about -0.58%. Currently the company’s common shares owned by public are about 231.72M shares, out of which, 223.70M shares are available for trading.
Stock saw a price change of -1.20% in past 5 days and over the past one month there was a price change of -5.86%. Year-to-date (YTD), HOLX shares are showing a performance of 5.09% which increased to 7.27% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $68.15 but also hit the highest price of $84.67 during that period. The average intraday trading volume for Hologic, Inc shares is 1.62 million. The stock is currently trading -3.41% below its 20-day simple moving average (SMA20), while that difference is down -5.48% for SMA50 and it goes to -3.51% lower than SMA200.
Hologic, Inc (NASDAQ: HOLX) currently have 231.72M outstanding shares and institutions hold larger chunk of about 103.49% of that.
The stock has a current market capitalization of $17.04B and its 3Y-monthly beta is at 0.96. PE ratio of stock for trailing 12 months is 22.61, while it has posted earnings per share of $3.32 in the same period. Its PEG reads 2.26 and has Quick Ratio of 3.03 while making debt-to-equity ratio of 0.52. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for HOLX, volatility over the week remained 3.29% while standing at 2.01% over the month.
Stock’s fiscal year EPS is expected to rise by 4.85% while it is estimated to increase by 9.91% in next year.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Needham on December 10, 2024 offering a Buy rating for the stock and assigned a target price of $90 to it. Coverage by Jefferies stated Hologic, Inc (HOLX) stock as a Hold in their note to investors on December 10, 2024, suggesting a price target of $85 for the stock. On October 01, 2024, Citigroup Downgrade their recommendations, while on June 27, 2024, Stephens Initiated their ratings for the stock with a price target of $87. Stock get a Buy rating from Citigroup on April 03, 2024.
